![Combining “Bottom‐up” and “Top‐down” Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC‐0941) Pharmacokinetics - Lu - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library Combining “Bottom‐up” and “Top‐down” Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC‐0941) Pharmacokinetics - Lu - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/ad005f80-dc25-46ab-9a47-c326a24d6e98/psp412228-fig-0003-m.jpg)
Combining “Bottom‐up” and “Top‐down” Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC‐0941) Pharmacokinetics - Lu - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
![Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | SpringerLink Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10928-019-09637-4/MediaObjects/10928_2019_9637_Fig3_HTML.png)
Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | SpringerLink
![Population pharmacokinetic analysis of weekly and biweekly IgPro20 (Hizentra®) dosing in patients with primary immunodeficiency - ScienceDirect Population pharmacokinetic analysis of weekly and biweekly IgPro20 (Hizentra®) dosing in patients with primary immunodeficiency - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1567576919315929-gr1.jpg)
Population pharmacokinetic analysis of weekly and biweekly IgPro20 (Hizentra®) dosing in patients with primary immunodeficiency - ScienceDirect
![Fitusiran Population Pharmacokinetic and Pharmacodynamic (PopPK/PD) Modeling to Support Revised Dose, Dosing Regimens & Dose Mitigation Scheme - ISTH Congress Abstracts Fitusiran Population Pharmacokinetic and Pharmacodynamic (PopPK/PD) Modeling to Support Revised Dose, Dosing Regimens & Dose Mitigation Scheme - ISTH Congress Abstracts](https://abstracts.isth.org/wp-content/uploads/2021/06/732_conclusions_1.jpg)
Fitusiran Population Pharmacokinetic and Pharmacodynamic (PopPK/PD) Modeling to Support Revised Dose, Dosing Regimens & Dose Mitigation Scheme - ISTH Congress Abstracts
![Supplemental Materials for Population Pharmacokinetics of High-Dose Methotrexate in Patients With Primary Central Nervous System Lymphoma - Journal of Pharmaceutical Sciences Supplemental Materials for Population Pharmacokinetics of High-Dose Methotrexate in Patients With Primary Central Nervous System Lymphoma - Journal of Pharmaceutical Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fd88c47c-eccc-4f96-af44-f95838ab3017/gr1.jpg)
Supplemental Materials for Population Pharmacokinetics of High-Dose Methotrexate in Patients With Primary Central Nervous System Lymphoma - Journal of Pharmaceutical Sciences
PLOS ONE: Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs
![Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia | BMJ Open Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/8/8/e020070/F3.large.jpg)
Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia | BMJ Open
Visual predictive testing of the Final Pop PK Model. Gray points are... | Download Scientific Diagram
Johnny Pop Kettle Corn 36/PK | Kitchen | Indoor | For the Home | John Deere products | JohnDeereStore
![Frontiers | Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing—Using Rifampicin as an Example | Pharmacology Frontiers | Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing—Using Rifampicin as an Example | Pharmacology](https://www.frontiersin.org/files/Articles/512473/fphar-11-00794-HTML/image_m/fphar-11-00794-g001.jpg)
Frontiers | Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing—Using Rifampicin as an Example | Pharmacology
![Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate | SpringerLink Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-020-00859-1/MediaObjects/40262_2020_859_Fig2_HTML.png)
Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate | SpringerLink
![Role of pharmacokinetic modeling and simulation in precision dosing of anticancer drugs - Darwich - Translational Cancer Research Role of pharmacokinetic modeling and simulation in precision dosing of anticancer drugs - Darwich - Translational Cancer Research](https://cdn.amegroups.cn/journals/pbpc/files/journals/3/articles/17108/public/17108-PB5-R1.png/w300)
Role of pharmacokinetic modeling and simulation in precision dosing of anticancer drugs - Darwich - Translational Cancer Research
![Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate | SpringerLink Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-020-00859-1/MediaObjects/40262_2020_859_Fig1_HTML.png)